India based Dr Bansal develops technologies to improve water solubility of medicines so that they are more effective for patients
India based Dr Bansal develops technologies to improve water solubility of medicines so that they are more effective for patients

NEW YORK (TIP): Arvind Kumar Bansal, a professor and head of the department of pharmaceutics at the National Institute of Pharmaceutical Education and Research (NIPER) in India, has been nominated by The American Association of Pharmaceutical Scientists (AAPS) as one of its Fellows, 2016.

AAPS announced the elevation of nine recipients to Fellow, one of the highest honors given to members of the association.

Each year, AAPS elevates a few members to Fellow in recognition of their professional excellence in fields relevant to AAPS’s mission: to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health.

Each Fellow has demonstrated a sustained level of superior and distinguished professional achievement and contributions in fields related to this mission. Fellows are nominated by supporters, selected by a committee of their peers, and elevated by AAPS’ Executive Council.

Dr Bansal develops technologies to improve water solubility of medicines so that they are more effective for patients. He is currently Professor and Head, department of Pharmaceutics at the National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar, Punjab, India. Dr. Bansal is leading a group of about 15 post-graduate and doctorate students, in various areas of Pharmaceutics like pre-formulation profiling, solid-state characterization, improvement of aqueous solubility, enhancement of oral bioavailability and compaction physics. Dr. Bansal holds a masters (1988) and doctorate degree (1993) in Pharmacy from the University of Delhi. Dr. Bansal served in the pharmaceutical industry as a research scientist in major Indian pharmaceutical companies – JK Pharmaceuticals (now called Regent Drugs after being acquired by Teva Pharmaceuticals, Israel) and Ranbaxy Laboratories Limited.